Incyte reports phase 1/2 trial results for bleeding disorder drug

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A ME Group reports first-half revenue rise amid mixed performance Hisse Senetleri 0 2
A Concurrent Technologies reports record first-half results Hisse Senetleri 0 2
A BMO upgrades Incyte stock rating on strategic progress Hisse Senetleri 0 9
A Incyte reports positive Phase 3 trial results for lymphoma drug Hisse Senetleri 0 12
A Bernstein initiates Incyte stock coverage with concerns on growth Hisse Senetleri 0 16
A Incyte president Pablo Cagnoni sells $1.76 million in stock Hisse Senetleri 0 45
A Form 8K Incyte Corporation For: 6 March Hisse Senetleri 0 22
A Form 13D/A Incyte Corp For: 10 February Hisse Senetleri 0 42

Benzer konular

Üst